J

Juan Martín-Liberal

Institut d'Investigació Biomédica de Bellvitge

ORCID: 0000-0003-2552-5172

253 papers and 3k citations.

PubIndex Score79Top 21% · mid-careerHow it's scored

253Publications

3kTotal Citations

First publication: 2013First senior author: 2013

Top publicationsby citations

First-in-human phase I/II, open-label study of the anti-OX40 agonist INCAGN01949 in patients with advanced solid tumors

Elizabeth J. Davis, Janice M. Mehnert, Dana B. Cardin et al.|Journal for ImmunoTherapy of Cancer|2022

Cited by 93

Phase I study and preclinical efficacy evaluation of the mTOR inhibitor sirolimus plus gemcitabine in patients with advanced solid tumours

Juan Martín-Liberal, Xavier García del Muro|British Journal of Cancer|2014

Cited by 20

961 Preliminary results of a phase 2 study of intratumoral administration of BO-112 with pembrolizumab in patients with advanced melanoma that have progressive disease on anti-PD-1-based therapy

Iván Márquez‐Rodas, Stéphane Dalle, Philippe Saïag et al.|Unknown|2021

Cited by 8

Indexing the rest of 253 publications…